Breaking News

Olon Expands High Containment API Operations

The CDMO plans to invest €27 million over the next two years including a newly commissioned production line.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The contract development and manufacturing organization (CDMO), Olon S.p.A., has unveiled plans to invest in its global high containment manufacturing operations. The international active pharmaceutical ingredient (API) supplier will be rolling out an investment of €27 million over 2022/2023 totally allocated to the expansion of internal expertise and high containment production capacity. Olon said that it has just completed a new large scale high containment production line (OEL < 1 mg/m3...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters